Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Urological Oncology: Bladder, Penis and Urethral Cancer, and Basic Principles of Oncology.

The Journal of Urology, 19 Aug 2022, 208(5):1158-1159
https://doi.org/10.1097/ju.0000000000002914 PMID: 35984094 

This is a comment on "Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer." J Clin Oncol. 2021 Oct 1;39(28):3140-3148. This is a comment on "Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)." J Clin Oncol. 2021 Aug 1;39(22):2486-2496. This is a comment on "ctDNA guiding adjuvant immunotherapy in urothelial carcinoma." Nature. 2021 Jul;595(7867):432-437.

Abstract 

No abstract provided.

Full text links 

Read article at publisher's site: https://doi.org/10.1097/ju.0000000000002914

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.